Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Block in Robotic Prostatectomy
NCT03420937Phase 4Completed
- Sponsor
- University Hospital Olomouc
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in prostate cancer (PCa), sponsored by University Hospital Olomouc. Started Jun 2016; status: completed.
02
Drugs
Sugammadex
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03420937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420937.